Capstone Investment Advisors, LLC Nektar Therapeutics Call Options Transaction History

Capstone Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $305,166 - $424,264	-18,100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$14.47 - $27.96 $195,345 - $377,460	13,500 Added 293.48%	18,100 $323,000
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $5,073 - $10,881	300 Added 6.98%	4,600 $84,000
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $127,100 - $148,830	4,100 Added 2050.0%	4,300 $153,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $9,292 - $13,697	200 New	200 $12,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $247M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.